Who are Pathogen reduction process's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/pathogen-reduction-process.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Pathogen reduction process — Competitive Intelligence Brief

Pathogen reduction process (Pathogen reduction process) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Blood product safety technology. Area: Hematology / Transfusion Medicine.

marketed Blood product safety technology Hematology / Transfusion Medicine Biologic Live · refreshed every 30 min

Target snapshot

Pathogen reduction process (Pathogen reduction process) — Etablissement Français du Sang. A pathogen reduction technology that inactivates viruses, bacteria, and other pathogens in blood products through chemical or physical treatment to improve transfusion safety.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Pathogen reduction process TARGET	Pathogen reduction process	Etablissement Français du Sang	marketed	Blood product safety technology

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Blood product safety technology class)

Etablissement Français du Sang · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pathogen reduction process — Competitive Intelligence Brief. https://druglandscape.com/ci/pathogen-reduction-process. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab